Switching to iGlarLixi Versus ContinuingDailyorWeeklyGLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial

Pridané:
12.12.2019
Autori: 
Lawrence Blonde,1 Julio Rosenstock,2 Stefano Del Prato,3 Robert Henry,4 Naim Shehadeh,5 Juan Frias,6 Elisabeth Niemoeller,7 Elisabeth Souhami,8 Chen Ji,9 and Vanita R. Aroda10
Zdroj: 
Diabetes Care
LINK NA ORIGINÁLNY ČLÁNOK
Dokumenty: 
PDF icon lixilan-g_blonde_publ.pdf